select a format

Single User License
USD 250 INR 0
Site License
USD 500 INR 0
Corporate User License
USD 750 INR 0

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


University of Pennsylvania-Pharmaceuticals & Healthcare-Deals and Alliances Profile

University of Pennsylvania-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH67297D
  • |
  • Pages: 81
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, criminology, fine arts, finance, operations and information management, telecommunications, theatre arts, and visual studies, among others. Its schools include school of arts and sciences, school of dental medicine, school of design, school of engineering and applied science, school of medicine and school of nursing. The university also offers arts, athletics, healthcare, libraries, online learning and global service facilities. UOP is headquartered in Philadelphia, Pennsylvania, the US.

University of Pennsylvania-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

University of Pennsylvania, Medical Devices Deals, 2011 to YTD 2017 12

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13

University of Pennsylvania, Pharmaceuticals & Healthcare, Deal Details 16

Partnerships 16

Incyte Enters into Research Agreement with Abramson Cancer Center 16

Tempus Health Enters into Agreement with Penn Medicine 17

Liquid Biotech Enters into Research Agreement with University of Pennsylvania 17

Celgene Enters into Co-Development Agreement with Abramson Cancer Center 18

Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 19

Biogen Enters into Co-Development Agreement with University of Pennsylvania 19

Seres Therapeutics Enters into Agreement with University of Pennsylvania 21

Audentes Therapeutics Amends Co-Development with University of Pennsylvania 21

Genisphere Enters into Research Agreement with University of Pennsylvania 22

NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 23

Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 24

Janssen Pharma Enters into Agreement with University of Pennsylvania 24

Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 25

Epic Sciences Partners with Abramson Cancer Center 26

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 27

PTC Therapeutics Enters into Agreement with University of Pennsylvania 27

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 28

Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 29

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 30

PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 31

Licensing Agreements 32

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 32

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 32

Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 33

Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 34

Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 35

Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 36

Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 37

Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 38

Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 39

Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 40

Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 41

ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 42

Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 43

Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 44

Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 45

Equity Offering 46

Tmunity Therapeutics Raises USD10 Million in Equity Financing 46

Asset Transactions 47

University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 47

Acquisition 48

University of Pennsylvania Health System To Acquire Chester County Hospital 48

University of Pennsylvania-Key Competitors 49

Key Employees 50

Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Recent Developments 52

Government and Public Interest 52

Feb 24, 2017: Penn Vet Team Identifies New Therapeutic Targets for the Tropical Disease Leishmaniasis 52

Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 54

Sep 30, 2016: Penn Scientists Receive $24 Million from National Science Foundation to Establish MechanoBiology Center 56

Aug 02, 2016: Cancer checkpoint drug target governs metabolic changes in exhausted T cells 58

Jul 28, 2016: Bayer Recognizes Research in Hemophilia and Bleeding Disorders for Fourteenth Straight Year 59

Jul 25, 2016: Scientists Test Ways to Discuss Opioid Risks With ER Patients 60

Jul 13, 2016: The Wistar Institute and Partners Receive Nearly $23 Million from NIH to Advance HIV Cure Research 61

Jun 21, 2016: New CAR T cell therapy using double target aimed at solid tumors 62

May 27, 2016: Identifying How Merkel Cell Polyomavirus Infection can Cause a Lethal Carcinoma 63

May 25, 2016: International, Multi-Institutional, Women-Led Research Team Receives $900,000 Research Grant from L'Oreal Paris USA and Melanoma Research Alliance to Study Metastatic Melanoma 64

Apr 07, 2016: Helmsley Charitable Trust Awards $2.1 Million to Penn, Stanford and Seattle Children's Research Institute to Explore Cell-Based Therapies for Type 1 Diabetes 66

Mar 30, 2016: Naltrexone is alternative treatment for opioid addiction, Penn-led study finds 67

Mar 28, 2016: Structure of Parkinson's protein could lead to new diagnostic and treatment options 68

Mar 18, 2016: Penn Researchers Show Rising Opioid Prescriptions Following Low-Risk Surgeries 69

Mar 17, 2016: Treating HIV patients at risk for tuberculosis with TB drugs doesn't save more lives 70

Mar 15, 2016: Study Suggests Reduced Immunosuppression Drug Dose May Be Best for Kidney Transplant Outcomes 71

Feb 18, 2016: Penn research: An FDA-approved Alzheimer's drug could help smokers quit 72

Product News 74

Nov 30, 2016: Penn Scientists Use CRISPR for First Time to Correct Clotting in Newborn and Adult Mice 74

Aug 02, 2016: Penn Researchers Improve Computer Modeling for Designing Drug-delivery Nanocarriers 75

Jul 20, 2016: Penn-led team develops plant-based Polio booster vaccine 76

Jun 30, 2016: New therapy treats autoimmune disease without harming normal immunity 78

Other Significant Developments 80

Oct 27, 2016: Janssen Partners with University of Pennsylvania and Castleman Disease Collaborative Network to Launch First Global Patient Registry for Castleman Disease 80

Appendix 81

Methodology 81

About GlobalData 81

Contact Us 81

Disclaimer 81

List of Figures

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

University of Pennsylvania, Medical Devices Deals, 2011 to YTD 2017 12

List of Tables

University of Pennsylvania, Pharmaceuticals & Healthcare, Key Facts, 2015 1

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

University of Pennsylvania, Deals By Therapy Area, 2011 to YTD 2017 10

University of Pennsylvania, Medical Devices Deals, 2011 to YTD 2017 12

University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13

Incyte Enters into Research Agreement with Abramson Cancer Center 16

Tempus Health Enters into Agreement with Penn Medicine 17

Liquid Biotech Enters into Research Agreement with University of Pennsylvania 17

Celgene Enters into Co-Development Agreement with Abramson Cancer Center 18

Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 19

Biogen Enters into Co-Development Agreement with University of Pennsylvania 19

Seres Therapeutics Enters into Agreement with University of Pennsylvania 21

Audentes Therapeutics Amends Co-Development with University of Pennsylvania 21

Genisphere Enters into Research Agreement with University of Pennsylvania 22

NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 23

Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 24

Janssen Pharma Enters into Agreement with University of Pennsylvania 24

Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 25

Epic Sciences Partners with Abramson Cancer Center 26

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 27

PTC Therapeutics Enters into Agreement with University of Pennsylvania 27

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 28

Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 29

Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 30

PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 31

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 32

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 32

Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 33

Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 34

Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 35

Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 36

Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 37

Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 38

Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 39

Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 40

Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 41

ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 42

Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 43

Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 44

Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 45

Tmunity Therapeutics Raises USD10 Million in Equity Financing 46

University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 47

University of Pennsylvania Health System To Acquire Chester County Hospital 48

University of Pennsylvania, Key Competitors 49

University of Pennsylvania, Key Employees 50

University of Pennsylvania, Subsidiaries 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

University of Pennsylvania, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com